Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Stephen Chen
AddedApr 2, 2024
UpdatedMay 31, 2026
Stephen Chen

Stephen Chen

Co-Founder, Capture

LinkedInTwitter

Stephen Chen's Career

Capture
Capture

New York City, NY, US

Co-Founder
Scanwell Health
Scanwell Health
Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Stephen Chen's Career

Capture
Capture
Seed$150k02018New York City, NY, US
Co-Founder

Leadership at Capture

Calvin LeGassickCalvin LeGassickCo-Founder

Similar to Capture

CaptureMyMeetingCaptureMyMeetingDover, DE, USMeeting Softwareest. 2018CaptureMyMeetingDover, DE, US · est. 2018

CaptureMyMeeting: An AI-powered platform for tracking, analyzing, and managing your meeting content.

Pre-Seed · $250k3
TaskadeTaskadeNew York City, NY, USProductivity Softwareest. 2017TaskadeNew York City, NY, US · est. 2017

AI-powered Taskade: Enhance team productivity with real-time collaboration and organization.

Seed · $5M17
IndexIndexSan Francisco, CA, USProduct Planningest. 2023IndexSan Francisco, CA, US · est. 2023

Index: Collaborative planning tool for tech growth, from ideas to plans.

Pre-Seed · $500k6
SidenoteSidenoteStanford, CA, USMeeting Softwareest. 2023SidenoteStanford, CA, US · est. 2023

Sidenote: Automates meeting notes into emails, invites, and tasks. A self-funded SaaS holding firm.

Pre-Seed · $500k3
Scanwell Health
Scanwell Health
Acquired$120k02018
Founder

Similar to Scanwell Health

Accessible DiagnosticsAccessible DiagnosticsGreenville, SC, USMedical Testsest. 2014Accessible DiagnosticsGreenville, SC, US · est. 2014

Accessible Diagnostics: Providing at-home, smartphone-based medical tests for healthier families.

Seed · $219k3
Wavely DiagnosticsWavely DiagnosticsSeattle, WA, USDiagnostic Appsest. 2018Wavely DiagnosticsSeattle, WA, US · est. 2018

Wavely Diagnostics: Pioneering remote digital diagnostics and telehealth growth via smartphone tech.

Seed · $5.6M11
Tuli HealthTuli HealthDiagnostic Testsest. 2021Tuli Healthest. 2021

Turning UK pharmacies into diagnostic centers, offering convenient testing services.

Seed · $125k4

Stephen Chen's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailBrian KimBrian KimCo-Founder · KakaoKim Beom-sooKim Beom-sooCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao

People Similar to Stephen Chen

Henry LiuHenry LiuFounder · FamilyLeafStephen JohnsonStephen JohnsonFounder · OneChronosKingsong ChenKingsong ChenCo-Founder · Scanate/FellowStephen GrinichStephen GrinichFounder · HealthSparkChristopher ChenChristopher ChenFounder · TrapezeStephen NiStephen NiFounder · Bluma